NeoLumina
  • Home
  • About us
  • Team
  • Investors
  • Press Releases
  • Blog
  • Contact
Select Page
Vital report explores employment in the psychedelics industry

Vital report explores employment in the psychedelics industry

by Admin Neo Lumina | Jan 19, 2024 | News

Vital report explores employment in the psychedelics industry Psychedelics Today recently surveyed students and graduates of its 12-month intensive professional psychedelic certification programme, Vital, publishing its findings in The Emerging Psychedelic Workforce...
Europe to establish regulatory guidance on psychedelics in 2024

Europe to establish regulatory guidance on psychedelics in 2024

by Admin Neo Lumina | Jan 19, 2024 | News

Europe to establish regulatory guidance on psychedelics in 2024 The European Medicines Agency (EMA) is set to hold a multi-stakeholder workshop on medical psychedelics in April 2024 to establish regulatory guidelines for the development and therapeutic use of...
Filament Health Completes The First Export Of Botanical Psilocybin To Australia

Filament Health Completes The First Export Of Botanical Psilocybin To Australia

by Admin Neo Lumina | Jan 19, 2024 | News

Filament Health Completes The First Export Of Botanical Psilocybin To Australia Reset Mind Sciences Ltd. has received a shipment of PEX010, Filament’s botanical psilocybin drug candidate Vancouver, British Columbia, January 17, 2024 – Filament Health...
NeoLumina Bioscience Podcast – Episode #1 – Gaetano Morello, ND

NeoLumina Bioscience Podcast – Episode #1 – Gaetano Morello, ND

by Admin Neo Lumina | Jan 9, 2024 | News

https://www.youtube.com/watch?v=hZAjlikBOk0 Dr. Morello NeoLumina Founder, Director and CEO is an accomplished naturopathic clinician and nutraceutical entrepreneur with over 30 years of experience. We go thru Gaetano’s background, his take on psychedelics,...
Are Psychedelics the Future of Eating Disorder Treatment?

Are Psychedelics the Future of Eating Disorder Treatment?

by Admin Neo Lumina | Jan 9, 2024 | News

Are Psychedelics the Future of Eating Disorder Treatment? The drugs have been shown to reduce depression and anxiety symptoms and make individuals more flexible in their thinking Sarah Kelley was 14 years old when she first started to feel an intractable need to...
« Older Entries
Next Entries »
Designed by NeoLumina Bio